Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

DAXOR CORPORATION

(DXR)
  Rapport
Vertraagde tijd Nyse  -  17:38 28-09-2022
13.58 USD   +1.88%
25/08Daxor Corporation maakt winstcijfers bekend voor het halfjaar dat eindigde op 30 juni 2022
CI
21/07Daxor Corporation kondigt partnerschap met Medaxiom aan
CI
27/06Daxor en de Uniformed Services University gaan samenwerken aan een nieuw apparaat voor de analyse van het bloedvolume
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciënConsensusBeursproductenFonds 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiële publicatiesSectornieuws
Nieuws in andere talen op DAXOR CORPORATION
26/09Daxor Corporation to Exhibit at the Annual Scientific Meeting of the Heart Failure Soci..
26/09Daxor Corporation to Exhibit at the Annual Scientific Meeting of the Heart Failure Soci..
06/09Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conferenc..
06/09Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conferenc..
29/08Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Lett..
29/08Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Lett..
25/08Daxor Corporation Reports a 92.6 Percent Revenue Increase in Diagnostic Operating Divis..
25/08Daxor Corporation Reports a 92.6 Percent Revenue Increase in Diagnostic Operating Divis..
25/08Tranche Update on Daxor Corporation's Equity Buyback Plan announced on January 14, 2007..
25/08Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2022
24/08Daxor Corporation to Report First Half 2022 Financial Results on Thursday, August 25, 2..
24/08Daxor Corporation to Report First Half 2022 Financial Results on Thursday, August 25, 2..
27/07Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Ove..
27/07Daxor Corporation Announces a 49.4% Increase In Its Single-Use Diagnostic Kits Year-Ove..
21/07Daxor corporation announces partnership with medaxiom to advance awareness and further ..
21/07Daxor corporation announces partnership with medaxiom to advance awareness and further ..
21/07Daxor Corporation Announces Partnership with Medaxiom
18/07Daxor completes nih funded i-corps program for commercialization of clinical decision s..
18/07Daxor completes nih funded i-corps program for commercialization of clinical decision s..
29/06Daxor Corp : Submission of Matters to a Vote of Security Holders (form 8-K)
27/06Daxor, The Uniformed Services University to Collaborate on New Blood Volume Analysis De..
27/06Daxor announces cooperative research and development phase ii agreement with the unifor..
27/06Daxor announces cooperative research and development phase ii agreement with the unifor..
27/06Daxor Corporation Announces Cooperative Research and Development Phase II Agreement wit..
13/06Daxor Corporation to Showcase the Benefits of BVA-100® Guided-Care at the American Asso..
13/06Daxor Corporation to Showcase the Benefits of BVA-100® Guided-Care at the American Asso..
25/05Daxor's Blood Volume Analyzer (BVA-100®) To Be Used As a Key Metric in Study of “..
25/05Daxor's Blood Volume Analyzer (BVA-100®) To Be Used As a Key Metric in Study of “..
12/05Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Confere..
12/05Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Confere..
02/05New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients wit..
02/05New Data Validates Blood Volume Analysis Guided-Care, Improves Survival in Patients wit..
02/05Daxor Corporation Announces New Data Validating the Benefits of its BVA-100 Blood Test
06/04New Study from Duke Heart Demonstrates the Unique Accuracy and Utility of Daxor's Blood..
23/03Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference
01/03Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Lett..
01/03Daxor Corporation Announces $1.35 Per Share NAV Increase and Files Annual Report for Fi..
28/02Daxor Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
28/02Tranche Update on Daxor Corporation's Equity Buyback Plan announced on January 14, 2007..
17/02Study Demonstrates Importance and Clinical Utility of Daxor's Blood Volume (BVA-100®) D..
17/02Daxor Corporation Announces New Data Demonstrating the Importance and Clinical Utility ..
02/02Daxor : Commences Trading on The NASDAQ Capital Market - Form 8-K
02/02Daxor Corp : Other Events (form 8-K)
02/02Daxor Corporation Commences Trading on The NASDAQ Capital Market
24/01Daxor Corp : Change in Directors or Principal Officers (form 8-K)
21/01Caleb DesRosiers, JD, MPA Appointed to Daxor Corporation Board of Directors
21/01Daxor Corporation Appoints Caleb Desrosiers, JD, MPA to its Board of Directors
20/01Daxor : to Commence Trading on The Nasdaq Capital Market On February 2, 2022 - Form 8-K
20/01Daxor Corp : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standar..
20/01Daxor Corporation to Commence Trading on The Nasdaq Capital Market On February 2, 2022
06/01Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
05/01Daxor announces key milestones achieved for multicenter bva-100® study in hospitalized ..
05/01Daxor Corporation Announces Patient Enrollment Completion and Updates Data Analysis
04/01Daxor awarded new patent for blood volume guidance technology to improve treatment and ..
2021Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test f..
2021New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100®)..
2021Daxor Corporation Announces New Data Demonstrating the Clinical Utility of the BVA-100 ..
2021Daxor Corporation : Receives $200K Matching Fund Award from Launch Tennessee
2021Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test f..
2021Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test f..
2021Daxor Corporation : To Present Compelling New Data and Clinical Trials Utilizing the BVA-1..
2021Daxor Corporation : to Present at the H.C. Wainwright 23rd Annual Global Investment Virtua..
2021Daxor Corporation : CEO and President Michael Feldschuh Provides Corporate Update in Lette..
2021Daxor Corporation : Reports a 26.5 Percent Rise in Diagnostic Sales Revenue in Form N-CSR ..
2021Tranche Update on Daxor Corporation's Equity Buyback Plan announced on January 14, 2007..
2021Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2021
2021Daxor : Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill..
2021Daxor : Announces non-government distribution agreement with concordance® healthcare solut..
2021Daxor Corporation Announces Non-Government Distribution Agreement with Concordance® Hea..
2021Daxor : American College of Cardiology (ACC) Features Expert Analysis on the Importance of..
2021Daxor Corporation Provides Update on American College of Cardiology Expert Analysis on ..
2021Daxor Corp : Submission of Matters to a Vote of Security Holders (form 8-K)
2021Daxor : to Present at the Summer Solstice – Best Ideas from the Buy Side Conference ..
2021Daxor Corporation to Present at the Summer Solstice - Best Ideas from the Buy Side Conf..
2021Daxor Corporation : Announces 61% Increase in Q1 2021 Sales Revenue and Further Acquisitio..
2021Daxor Corp : Other Events (form 8-K)
2021Daxor Corporation : Receives National Institutes of Health (NIH) Funding Notification for ..
2021Daxor Corporation Announces the Initiation of A Multi-Center Clinical Trial with Two Ve..
2021Daxor : Newly Published Study Demonstrates Clinical Utility of Daxor's Blood Volume (BVA-1..
2021Daxor Corporation Announces Newly Published Study Demonstrates Clinical Utility of Daxo..
2021Daxor corporation to participate in benzinga biotech small cap conference
2021Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference
2021Daxor Corp : Other Events (form 8-K)
2021Daxor corporation announces novel fluorescent tracer and phase-two us air force contrac..
2021Daxor Corporation Announces Novel Fluorescent Tracer and Phase-Two US Air Force Contrac..
2021Daxor to Present at the H.C. Wainwright Global Life Sciences Conference
2021Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fi..
2021Tranche Update on Daxor Corporation's Equity Buyback Plan announced on January 14, 2007..
2021Daxor Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
2021Daxor corporation receives iso 13485 quality management system certification for the bl..
2021Daxor corporation awarded grant from the center for advancing point of care technologie..
2021Daxor Corporation Awards Grant from the Center for Advancing Point of Care Technologies..
2021New Research Demonstrates the Clinical Utility with Daxor's Blood Volume Analyzer (BVA-..
2021Daxor Corporation Announces New Data from the University of Hawaii John A. Burns School..
2021Daxor : To exhibit at the society for critical care medicine 50th congress virtual event
2021Daxor : Announces new distribution agreement with l1 enterprises government distributor
2021Daxor Corporation Announces New Distribution Agreement with L1 Enterprises Government D..
2021Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference
2020Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer ..
2020Daxor Corporation : to Present at the 13th Annual LD Micro Main Event 2020